Spatial Transcriptomics of Micropapillary, Plasmacytoid, and Sarcomatoid Urothelial Carcinoma Reveals Distinct Molecular Landscapes
Authors:
- 25 August 2026
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (10) , 106160
Abstract
No abstract availableKeywords
Funding Information
- Harvard Medical School
- Massachusetts General Hospital
This publication has 35 references indexed in Scilit:
- A histopathological snapshot of bladder cancer: a Johannesburg experience of 1480 histopathology reportsWorld Journal of Urology, 2025
- Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cellsThe Journal of Pathology: Clinical Research, 2025
- Fixed or random? On the reliability of mixed‐effects models for a small number of levels in grouping variablesEcology and Evolution, 2022
- The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centreWorld Journal of Urology, 2020
- A Consensus Molecular Classification of Muscle-invasive Bladder CancerEuropean Urology, 2020
- Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeHuman Pathology, 2018
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical UseEBioMedicine, 2016
- Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerEuropean Urology, 2016
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline ChemotherapyCancer Cell, 2014
- The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinomaInternational Journal of Cancer, 2010